Companies that successfully use AI are those that understand technology magnifies accountability. Anyone that fails to internalize that lesson could find themselves defending the very systems they relied on to bring those products to market.
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
- RWD Helps Researchers Include More Patients In Lymphoma Research
- RWE Is Ready — Decision Making For Pharmaceuticals Isn't
- Building A Future-Proof, GxP-Compliant IT Infrastructure
- Unlocking Biopharma Innovation With Real-World Evidence
ON-DEMAND WEBINARS
Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.
During this webinar, speakers will discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer.
<p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>
Gain expert insights on the future of RTSM strategy and its evolution with the changing clinical supply and technology landscape in our webinar.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Wearable-health-innovation-GettyImages-1347130002]( "How Wearable Devices Improve Patient Engagement In Clinical Trials")
How Wearable Devices Improve Patient Engagement In Clinical TrialsWearables are no longer optional—they are foundational to the future of patient-centric, data-driven clinical research.
-
![GettyImages-2155531148 electronic data, ePRO, eCOA]( "Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice")
Why ePROs In Oncology Are Perfect For Capturing The Patient's VoiceRecently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.
-
Suvoda Products
Suvoda Products Listing.
-
![GettyImages-1314299046 econsent]( "10 FAQs On eConsent")
10 FAQs On eConsentClosely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.
-
![GettyImages-1257569927 patient tech]( "Patient-Centricity Is In Everything We Do: Designing Accessible eClinical Technology")
Patient-Centricity Is In Everything We Do: Designing Accessible eClinical TechnologyBy prioritizing patient centricity within an eClinical platform’s design, sponsors can tailor patient engagement to achieve outcomes based on a study’s indication, patient population, and end goals.
-
![Five 5]( "5 Ways Lab Data Can Help Commercialize Your Therapy")
5 Ways Lab Data Can Help Commercialize Your TherapyDelve into five pivotal insights for leveraging lab data effectively and the collaboration that accelerated market entry for new therapies while ensuring the needs of targeted populations were met.
-
![GettyImages-1169656849 eCOA]( "Setting Up An eCOA Trial In A DCT Context: What You Should Know")
Setting Up An eCOA Trial In A DCT Context: What You Should KnowConsider these three aspects when choosing an electronic Clinical Outcome Assessments (eCOA) provider and preparing to set up an eCOA clinical trial.
-
![GettyImages-836663414 medical team meeting]( "What Does EDC Look Like In 2024 And Beyond?")
What Does EDC Look Like In 2024 And Beyond?Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.
-
![GettyImages-1869998960 patient, doctor, clincial trial]( "Phase 4 Trials: A Critical Component Of Post-Marketing Insight")
Phase 4 Trials: A Critical Component Of Post-Marketing InsightUncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
![GettyImages-1251666666 team of dcotors clinical]( "Control And Transparency: Solving Sponsors' Key Challenges In Study Launch")
Control And Transparency: Solving Sponsors' Key Challenges In Study LaunchLearn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
RECENT NEWSLETTERS
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials
